Substance / Medication

Ferrous gluconate

Overview

Active Ingredient
ferrous gluconate
RxNorm CUI
24942

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Ferrous gluconate and ferrous sulfate added to a complementary food distributed by the Mexican nutrition program Oportunidades have a comparable efficacy to reduce iron deficiency in toddlers.
Shamah-Levy Teresa, Villalpando Salvador, Rivera-Dommarco Juan A et al. · J Pediatr Gastroenterol Nutr · 2008
PMID: 18979587RCT
Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers.
Villalpando Salvador, Shamah Teresa, Rivera Juan A et al. · J Nutr · 2006
PMID: 16988138RCT
Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
Jaber Lutfi, Rigler Shmuel, Taya Ahmad et al. · J Pediatr Hematol Oncol · 2010
PMID: 20930652Observational
Compensating for iron loss in regular blood donors using ferrous gluconate and ascorbic acid.
Radtke Hartmut, Tegtmeier Joanna, Röcker Lothar et al. · Transfusion · 2005
PMID: 15987376Observational
Thrombocytopenia following iron repletion with ferrous gluconate.
Al Saud Aljoharah A, AlRomaizan Muneerah R, Alkhunizan Muath A · Saudi Med J · 2024
PMID: 39074892Case ReportFull text (PMC)
Ferrous gluconate-loaded sodium alginate hydrogel facilitates ferroptosis in Streptococcus hemolyticus and cures Streptococcal infections.
Yao Lishan, Xiang Fukun, Peng Shurui et al. · Int J Biol Macromol · 2025
PMID: 40651645Other
Ferrous gluconate triggers ferroptosis in Escherichia coli: Implications of lipid peroxidation and DNA damage.
Jing Wenhui, Guo Rongxian, Zhu Xiaolin et al. · Microbiol Res · 2024
PMID: 38636240Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ferrous gluconate (substance)
SNOMED CT
387147005
UMLS CUI
C0060277
RxNorm CUI
24942

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

1
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.